A severe shortage hits a drug used for cancer, immune disorders, epilepsy, causing canceled treatments and rationing

Increased demand — along with the time it takes to manufacture the lifesaving immune globulin medicine — has led to limited supplies.

View original article
Contributor: Holly Rosenkrantz